R. M. Bonotto

Evaluation of broad-spectrum antiviral compounds against chikungunya infection using a phenotypic screening strategy

L. Figueiredo, L. Freitas-Junior, S. J. Badra, 2018, F1000Research.

Biological Properties of a Novel Multifunctional Host Defense Peptide from the Skin Secretion of the Chaco Tree Frog, Boana raniceps

B. D. Lima, C. Ricart, L. Freitas-Junior, 2020, Biomolecules.

Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors

A. Marcello, D. Lembo, M. Donalisio, 2021, Antiviral Research.

Identification of Novel Compounds Inhibiting Chikungunya Virus-Induced Cell Death by High Throughput Screening of a Kinase Inhibitor Library

O. Schwartz, L. Freitas-Junior, J. No, 2013, PLoS neglected tropical diseases.

Repurposing of Miglustat to inhibit the coronavirus Severe Acquired Respiratory Syndrome SARS-CoV-2

A. Marcello, N. Skoko, Sulena Polez, 2020, bioRxiv.

Combined in silico docking and in vitro antiviral testing for drug repurposing identified lurasidone and elbasvir as SARS-CoV-2 and HCoV-OC43 inhibitors

A. Marcello, D. Lembo, M. Donalisio, 2020, bioRxiv.

The influence on DNA damage of glycaemic parameters, oral antidiabetic drugs and polymorphisms of genes involved in the DNA repair system.

M. Perassolo, Jessica Meyer, D. Rovaris, 2013, Mutagenesis.